Daniel, Chris and Bhakta, Sanjib (2022) Immunobiology of tubercle bacilli and prospects of immunomodulatory drugs to tackle tuberculosis (TB) and other non-tubercular mycobacterial infections. Immunobiology 227 (3), ISSN 0171-2985.
|
Text
1-s2.0-S017129852200050X-main.pdf - Published Version of Record Available under License Creative Commons Attribution. Download (1MB) | Preview |
Abstract
The COVID-19 pandemic has set back progress made on antimicrobial resistance (AMR). Without urgent re-focus, we risk slowing down drug discovery and providing treatment for drug resistant Mycobacterium tuberculosis. Unique in its immune evasion, dormancy and resuscitation, the causal pathogens of tuberculosis (TB) have demonstrated resistance to antibiotics with efflux pumps and the ability to form biofilms. Repurposing drugs is a prospective avenue for finding new anti-TB drugs. There are many advantages to discovering novel targets of an existing drug, as the pharmacokinetic and pharmacodynamic properties have already been established, they are cost-efficient and can be commercially accelerated for the new development. One such group of drugs are non-steroidal anti-inflammatory drugs (NSAIDs) that are originally known for their ability to supress the host proinflammatory responses. In addition to their anti-inflammatory properties, some NSAIDs have been discovered to have antimicrobial modes of action. Of particular interest is Carprofen, identified to inhibit the efflux mechanism and disrupt biofilm formation in mycobacteria. Due to the complexities of host-pathogens interactions in the lung microbiome, inflammatory responses must carefully be controlled alongside the in vivo actions of the prospective anti-infectives. This critical review explores the potential dual role of a selection of NSAIDs, as an anti-inflammatory and anti-tubercular adjunct to reverse the tide of antimicrobial resistance in existing treatments.
Metadata
| Item Type: | Article |
|---|---|
| Keyword(s) / Subject(s): | NSAIDs, Carprofen, Tuberculosis, Mycobacterium tuberculosis (Mtb), Non-tubercular mycobacteria (NTM), Antimicrobial resistance (AMR), Drug repurposing |
| School: | Birkbeck Faculties and Schools > Faculty of Science > School of Natural Sciences |
| Depositing User: | Chris Daniel |
| Date Deposited: | 10 Aug 2023 14:45 |
| Last Modified: | 11 Aug 2023 00:08 |
| URI: | https://eprints.bbk.ac.uk/id/eprint/51731 |
Statistics
Additional statistics are available via IRStats2.
Archive Staff Only (login required)
